Parag Agarwal - Dr Reddys CFO Council
| RDDA Stock | EUR 13.70 0.20 1.48% |
Insider
Parag Agarwal is CFO Council of Dr Reddys Laboratories
| Age | 57 |
| Phone | 91 40 4900 2900 |
| Web | https://www.drreddys.com |
Dr Reddys Management Efficiency
The company has return on total asset (ROA) of 0.0949 % which means that it generated a profit of $0.0949 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1772 %, meaning that it generated $0.1772 on every $100 dollars invested by stockholders. Dr Reddys' management efficiency ratios could be used to measure how well Dr Reddys manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Steve McCaffery | Ribbon Communications | N/A | |
| Hon Ip | CITIC Telecom International | 52 | |
| Krish Prabhu | Ribbon Communications | 65 | |
| Beatriz Infante | Ribbon Communications | 65 | |
| Patrick Macken | Ribbon Communications | 49 | |
| Andrew Taylor | Gamma Communications plc | 54 | |
| Tanya Tamone | Ribbon Communications | N/A | |
| Dawei Cai | CITIC Telecom International | 45 | |
| Mun Tso | CITIC Telecom International | 61 | |
| Mariano Beer | Ribbon Communications | N/A | |
| Andy Morris | Gamma Communications plc | 52 | |
| Salvatore Bucci | Ribbon Communications | 58 | |
| Frank Ip | CITIC Telecom International | N/A | |
| Chris Bradford | Gamma Communications plc | N/A | |
| Sean Matthews | Ribbon Communications | N/A | |
| Julio Villafane | Ribbon Communications | N/A | |
| Richard Smith | Ribbon Communications | 66 | |
| R Ewing | Ribbon Communications | 67 | |
| Jamie Gibson | Ribbon Communications | N/A | |
| Sam Bucci | Ribbon Communications | N/A | |
| William Castell | Gamma Communications plc | N/A | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0949 |
Dr Reddys Laboratories Leadership Team
Elected by the shareholders, the Dr Reddys' board of directors comprises two types of representatives: Dr Reddys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RDDA. The board's role is to monitor Dr Reddys' management team and ensure that shareholders' interests are well served. Dr Reddys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dr Reddys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Parag Agarwal, CFO Council | ||
| Sanjay BTech, Global VP | ||
| Erez MBA, CEO Council | ||
| Gunupati BE, MD CoChairman | ||
| MS BTech, Chairman Council | ||
| MBA MBA, CEO Council | ||
| Deepak MBA, CEO Council |
RDDA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dr Reddys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0949 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 8.47 B | |||
| Shares Outstanding | 166.1 M | |||
| Shares Owned By Institutions | 10.37 % | |||
| Price To Earning | 23.95 X | |||
| Price To Book | 3.61 X | |||
| Price To Sales | 0.04 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in RDDA Stock
When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.